Cascade Pharmaceuticals, Inc
Clinical trials sponsored by Cascade Pharmaceuticals, Inc, explained in plain language.
-
New pill aims to shrink dangerous liver fat and shed pounds
Disease control Not yet recruitingThis study is testing if a new investigational pill, CS060380, works better than a placebo when added to an approved weight-loss injection (semaglutide) for people who have both a serious fatty liver disease (MASH) and obesity. About 120 adults in China will take either the new p…
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists test if a fatty meal changes how a new drug works
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how the experimental drug CS0159 is processed by the body. Researchers will test it in 32 healthy volunteers to see if taking it with a high-fat meal changes its effects, and how it interacts with two other common medications. The goal is…
Phase: PHASE1 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC